News

AliveCor, the leader in FDA-cleared mobile electrocardiogram (ECG) technology for mobile devices, announced that it will integrate data from Omron Healthcare Bluetooth®-enabled home blood pressure devices into its ECG Kardia Mobile...

St. Jude Medical, Inc., a global medical device company, announced the start of the St. Jude Medical AMPLATZER™ Amulet™ IDE trial, which will evaluate the safety and effectiveness of the company’s AMPLATZER™ Amulet™ Left Atrial...

During a scientific talk at the 2016 European Society of Cardiology (ESC) Congress, Dr. Gerhard Hindricks, Leipzig Heart Center, Germany, presented results of a meta-study showing that BIOTRONIK Home Monitoring® is associated with a 38...

In the largest and longest clinical evaluation of leadless pacing patients to date, Medtronic plc announced new long-term results from the Medtronic Micra® Transcatheter Pacing System (TPS) Global Clinical Trial in a clinical trial update...

First outcome results from the GLORIA™-AF Registry show that treatment with Pradaxa® (dabigatran etexilate mesylate) was associated with low incidences of stroke, major bleeding and life-threatening bleeding. The results from...

Biosense Webster, Inc., a worldwide leader in the treatment and diagnosis of heart arrhythmias, announced U.S. approval of the THERMOCOOL SMARTTOUCH® SF Catheter. The catheter, now available for sale in the United States, is the only approved...

Boehringer Ingelheim announced its global RE-VECTO program for Praxbind® (idarucizumab), the specific reversal agent for Pradaxa® (dabigatran etexilate mesylate). PRAXBIND is indicated for patients treated with PRADAXA, when reversal of the...

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance (MR) conditional labeling for all previously implanted...

Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced the market release of its second generation V-CAS Deflect™ catheter advancement system in Europe. The V-CAS Deflect...

Cardiome Pharma Corp. announced that it has expanded its management team with the addition of Mr. Frank Murphy, who will serve as Cardiome's Vice President of Finance, and Dr. David Palling, who will serve as the company's Vice President of...